
<rss version="2.0">
  <channel>
    <title>Y! Health Prostate Cancer News</title>
    <link>http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/</link>
    <description>Y! Health Prostate Cancer News, updated continuously.</description>
    <language>en-us</language>
    <lastBuildDate>Thu, 24 Jul 2008 13:59:30 PDT</lastBuildDate>
    <copyright>Copyright (c) 2008 Yahoo! Inc. All rights reserved.</copyright>
    <ttl>5</ttl>
    <image>
      <title>Yahoo! Health</title>
      <width>142</width>
      <height>18</height>
      <link>http://health.yahoo.com/</link>
      <url>http://us.i1.yimg.com/us.yimg.com/i/us/he/b/he_144.gif</url>
    </image><item><title>Health Highlights: July 23,  2008 (HealthDay)</title><link>http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/healthday/healthhighlightsjuly232008.html</link><guid isPermaLink="false">yahoo/health/news/healthday/healthhighlightsjuly232008</guid><pubDate>Wed, 23 Jul 2008 11:02:49 PDT</pubDate><description>HealthDay - Here are some of the latest health and medical news developments,
compiled by editors of HealthDay:</description></item><item><title>Health Highlights: July 22,  2008 (HealthDay)</title><link>http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/healthday/healthhighlightsjuly222008.html</link><guid isPermaLink="false">yahoo/health/news/healthday/healthhighlightsjuly222008</guid><pubDate>Tue, 22 Jul 2008 20:47:34 PDT</pubDate><description>HealthDay - Here are some of the latest health and medical news developments,
compiled by editors of HealthDay:</description></item><item><title>Lung Cancer Trial Targets Asbestos-Related Disease (HealthDay)</title><link>http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/healthday/lungcancertrialtargetsasbestosrelateddisease.html</link><guid isPermaLink="false">yahoo/health/news/healthday/lungcancertrialtargetsasbestosrelateddisease</guid><pubDate>Mon, 21 Jul 2008 20:47:22 PDT</pubDate><description>HealthDay - MONDAY, July 21 (HealthDay News) -- Patients are being recruited for a
clinical trial of a new targeted radiation and chemotherapy protocol for
pleural mesothelioma, a cancer of the lung&amp;#39;s lining that&amp;#39;s almost always
caused by exposure to asbestos.</description></item><item><title>New pill helps shrink prostate tumors: study (Reuters)</title><link>http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/reuters/prostate_cougar_dc.html</link><guid isPermaLink="false">yahoo/health/news/reuters/prostate_cougar_dc</guid><pubDate>Mon, 21 Jul 2008 16:02:42 PDT</pubDate><description>Reuters - A once-a-day pill significantly shrank 
tumors in men with advanced prostate cancer who had not 
responded to other treatments, researchers said on Tuesday.</description></item><item><title>Racial disparity seen in prostate cancer treatment (Reuters)</title><link>http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/reuters/racial_disparity_dc.html</link><guid isPermaLink="false">yahoo/health/news/reuters/racial_disparity_dc</guid><pubDate>Fri, 18 Jul 2008 10:36:05 PDT</pubDate><description>Reuters - Black men with early prostate 
cancer may be less likely to receive aggressive treatment than 
their white counterparts, a small study has found.</description></item><item><title>Cancer Survival Depends on Where You Live (HealthDay)</title><link>http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/healthday/cancersurvivaldependsonwhereyoulive.html</link><guid isPermaLink="false">yahoo/health/news/healthday/cancersurvivaldependsonwhereyoulive</guid><pubDate>Thu, 17 Jul 2008 20:48:15 PDT</pubDate><description>HealthDay - WEDNESDAY, July 16 (HealthDay News) -- Your odds of surviving
cancer depend on which country you live in. And, in the United States, it
also depends on whether you&amp;#39;re black or white, a new study finds.</description></item><item><title>Imaging Advance Tracks Prostate Cancer in  Lymph Nodes (HealthDay)</title><link>http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/healthday/imagingadvancetracksprostatecancerinlymphnodes.html</link><guid isPermaLink="false">yahoo/health/news/healthday/imagingadvancetracksprostatecancerinlymphnodes</guid><pubDate>Tue, 15 Jul 2008 20:46:31 PDT</pubDate><description>HealthDay - TUESDAY, July 15 (HealthDay News) -- A new imaging technique,
based on an engineered version of the common cold virus, may help doctors
detect the spread of prostate cancer to the lymph nodes earlier.</description></item><item><title>Hormone Therapy Not Shown to Benefit  Older Patients with Early Prostate Cancer (American Cancer Society)</title><link>http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/acs/hormone_therapy_not_shown_to_benefit_older_patients_with_early_prostate_cancer.html</link><guid isPermaLink="false">yahoo/health/news/acs/hormone_therapy_not_shown_to_benefit_older_patients_with_early_prostate_cancer</guid><pubDate>Tue, 15 Jul 2008 17:00:00 PDT</pubDate><description>American Cancer Society - A study of nearly 20,000 men aged 66 and older with 
early-stage
prostate cancer found that those who were prescribed androgen
deprivation hormone therapy instead of other treatments were no better
off than their counterparts who adopted a &quot;wait and see&quot; approach.
However, younger men who aren't good candidates for surgery or
radiation should still consider the therapy, which reduces androgen
levels and often makes prostate cancers shrink or grow more slowly.</description></item><item><title>Drug prevents bone loss in prostate cancer: Amgen (Reuters)</title><link>http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/reuters/amgen_denosumab_dc.html</link><guid isPermaLink="false">yahoo/health/news/reuters/amgen_denosumab_dc</guid><pubDate>Mon, 14 Jul 2008 11:36:33 PDT</pubDate><description>Reuters - In a study, Amgen Inc&amp;#39;s 
experimental drug denosumab reduced the risk of osteoporosis 
and fracture in men being treated with prostate cancer 
medicines that can cause bone loss, the company said on Monday.</description></item><item><title>ED from prostate cancer hormone therapy treatable (Reuters)</title><link>http://us.rd.yahoo.com/health/news/rss/search/*http://health.yahoo.com/news/reuters/ed_treatable_dc.html</link><guid isPermaLink="false">yahoo/health/news/reuters/ed_treatable_dc</guid><pubDate>Fri, 11 Jul 2008 09:47:27 PDT</pubDate><description>Reuters - A new study shows that a 
substantial minority of men receiving so-called androgen 
deprivation therapy, or ADT, for prostate cancer experience 
erectile dysfunction (ED). However, many respond well to ED 
therapy, doctors from Memphis have found.</description></item>  </channel>
</rss>
<!-- health:health-us:0:Success -->
<!-- fe5.health.sp1.yahoo.com uncompressed/chunked Thu Jul 24 14:02:12 PDT 2008 -->
